But to do that, we need lower prices, thoughtful coverage policies, and a clearer understanding of who benefits most. Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults was published in JAMA Health Forum in March 2025
Publication Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models
Later generations of models should consider this information when it becomes available
Yan-Do R, Duong E, Manning Fox JE, Dai X, Suzuki K, Khan S, et al
Headaches: Occasional mild headaches occur in some users, particularly during the first week